What is the new name for Alcoholic Liver Disease (ALD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The new name for Alcoholic Liver Disease (ALD) is indeed Alcohol-associated Liver Disease (ALD). This change in terminology, as suggested by the 2019 practice guidance from the American Association for the Study of Liver Diseases 1, aims to reduce the stigma associated with the condition by shifting the focus from the term "alcoholic" to "alcohol-associated". The term ALD encompasses a spectrum of liver injuries resulting from alcohol use, including hepatic steatosis, alcoholic hepatitis (AH), and alcohol-associated cirrhosis (AC) 1.

Key Points

  • The name change from Alcoholic Liver Disease to Alcohol-associated Liver Disease reflects a more accurate and less stigmatizing description of the condition.
  • ALD represents a spectrum of liver injury resulting from alcohol use, ranging from hepatic steatosis to more advanced forms including alcoholic hepatitis and cirrhosis.
  • The updated terminology is part of a broader effort in medicine to use more precise and patient-centered language, as noted in the 2019 practice guidance 1.
  • The pathophysiology of the disease remains unchanged, with alcohol and its metabolites causing direct hepatocyte damage, triggering inflammatory responses, and promoting oxidative stress in the liver.
  • Treatment for ALD still focuses on alcohol cessation, nutritional support, and management of complications, regardless of the name change, as outlined in the guidance 1.

Clinical Implications

The change in terminology to Alcohol-associated Liver Disease is significant because it acknowledges the association between alcohol use and liver disease without stigmatizing the patient. This shift in language can encourage patients to seek medical help without fear of judgment, potentially leading to earlier diagnosis and treatment. As healthcare providers, using the term Alcohol-associated Liver Disease can help foster a more supportive and non-judgmental environment for patients struggling with alcohol use and related liver conditions, in line with the recommendations from the American Association for the Study of Liver Diseases 1.

From the Research

Definition and Terminology

  • The term "Alcoholic Liver Disease (ALD)" is still widely used, but recent studies refer to it as "Alcohol-Associated Liver Disease" 2, 3, 4.
  • This change in terminology reflects the complexity of the disease and its association with alcohol consumption.

Current Understanding

  • Alcohol-Associated Liver Disease (ALD) encompasses a range of conditions, from steatosis to cirrhosis, and is a major cause of chronic liver disease 2, 3, 4.
  • The disease is characterized by a clinical-histologic spectrum of presentations, including steatohepatitis, fibrosis, and cirrhosis 2, 3.

Diagnosis and Treatment

  • Diagnosis of ALD requires documentation of chronic heavy alcohol use and exclusion of other causes of liver disease 5.
  • Treatment options for ALD include abstinence, nutritional support, and corticosteroids, as well as management of underlying alcohol-use disorder 2, 3, 4, 5.
  • Liver transplantation may be considered in selected patients with advanced cirrhosis or severe alcohol-associated hepatitis 3, 4, 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Current Medical Treatment for Alcohol-Associated Liver Disease.

Journal of clinical and experimental hepatology, 2022

Research

ACG Clinical Guideline: Alcohol-Associated Liver Disease.

The American journal of gastroenterology, 2024

Research

ACG Clinical Guideline: Alcoholic Liver Disease.

The American journal of gastroenterology, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.